137 related articles for article (PubMed ID: 21502100)
1. Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme.
Snelgrove RJ
Thorax; 2011 Jun; 66(6):550-1. PubMed ID: 21502100
[TBL] [Abstract][Full Text] [Related]
2. The development of novel LTA
Low CM; Akthar S; Patel DF; Löser S; Wong CT; Jackson PL; Blalock JE; Hare SA; Lloyd CM; Snelgrove RJ
Sci Rep; 2017 Mar; 7():44449. PubMed ID: 28303931
[TBL] [Abstract][Full Text] [Related]
3. An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease.
Wells JM; O'Reilly PJ; Szul T; Sullivan DI; Handley G; Garrett C; McNicholas CM; Roda MA; Miller BE; Tal-Singer R; Gaggar A; Rennard SI; Jackson PL; Blalock JE
Am J Respir Crit Care Med; 2014 Jul; 190(1):51-61. PubMed ID: 24874071
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
Numao S; Hasler F; Laguerre C; Srinivas H; Wack N; Jäger P; Schmid A; Osmont A; Röthlisberger P; Houguenade J; Bergsdorf C; Dawson J; Carte N; Hofmann A; Markert C; Hardaker L; Billich A; Wolf RM; Penno CA; Bollbuck B; Miltz W; Röhn TA
Sci Rep; 2017 Oct; 7(1):13591. PubMed ID: 29051536
[TBL] [Abstract][Full Text] [Related]
5. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.
Snelgrove RJ; Jackson PL; Hardison MT; Noerager BD; Kinloch A; Gaggar A; Shastry S; Rowe SM; Shim YM; Hussell T; Blalock JE
Science; 2010 Oct; 330(6000):90-4. PubMed ID: 20813919
[TBL] [Abstract][Full Text] [Related]
6. Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.
Akthar S; Patel DF; Beale RC; Peiró T; Xu X; Gaggar A; Jackson PL; Blalock JE; Lloyd CM; Snelgrove RJ
Nat Commun; 2015 Sep; 6():8423. PubMed ID: 26400771
[TBL] [Abstract][Full Text] [Related]
7. Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema.
Paige M; Wang K; Burdick M; Park S; Cha J; Jeffery E; Sherman N; Shim YM
J Immunol; 2014 Jun; 192(11):5059-68. PubMed ID: 24771855
[TBL] [Abstract][Full Text] [Related]
8. An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.
Patel DF; Peiró T; Shoemark A; Akthar S; Walker SA; Grabiec AM; Jackson PL; Hussell T; Gaggar A; Xu X; Trevor JL; Li J; Steele C; Tavernier G; Blalock JE; Niven RM; Gregory LG; Simpson A; Lloyd CM; Snelgrove RJ
Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135247
[TBL] [Abstract][Full Text] [Related]
9. Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.
Stsiapanava A; Olsson U; Wan M; Kleinschmidt T; Rutishauser D; Zubarev RA; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4227-32. PubMed ID: 24591641
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene A4 hydrolase as a target for cancer prevention and therapy.
Chen X; Wang S; Wu N; Yang CS
Curr Cancer Drug Targets; 2004 May; 4(3):267-83. PubMed ID: 15134534
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors.
Röhn TA; Numao S; Otto H; Loesche C; Thoma G
Expert Opin Drug Discov; 2021 Dec; 16(12):1483-1495. PubMed ID: 34191664
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A
Teder T; König S; Singh R; Samuelsson B; Werz O; Garscha U; Haeggström JZ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108702
[TBL] [Abstract][Full Text] [Related]
13. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
Appiah-Kubi P; Soliman ME
J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
[TBL] [Abstract][Full Text] [Related]
14. Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase.
Fourie AM
Curr Opin Investig Drugs; 2009 Nov; 10(11):1173-82. PubMed ID: 19876785
[TBL] [Abstract][Full Text] [Related]
15. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
[TBL] [Abstract][Full Text] [Related]
16. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.
Turnbull AR; Pyle CJ; Patel DF; Jackson PL; Hilliard TN; Regamey N; Tan HL; Brown S; Thursfield R; Short C; Mc Fie M; Alton EWFW; Gaggar A; Blalock JE; Lloyd CM; Bush A; Davies JC; Snelgrove RJ
J Cyst Fibros; 2020 Jan; 19(1):40-48. PubMed ID: 31176670
[TBL] [Abstract][Full Text] [Related]
17. Targeting of a common receptor shared by CXCL8 and N-Ac-PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases.
Snelgrove RJ
Eur J Pharmacol; 2011 Sep; 667(1-3):1-5. PubMed ID: 21669195
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke enhances chemotaxis via acetylation of proline-glycine-proline.
Hardison MT; Brown MD; Snelgrove RJ; Blalock JE; Jackson P
Front Biosci (Elite Ed); 2012 Jun; 4(7):2402-9. PubMed ID: 22652647
[TBL] [Abstract][Full Text] [Related]
19. Effect of Modifier Structure on the Activation of Leukotriene A
Lee KH; Petruncio G; Shim A; Burdick M; Zhang Z; Shim YM; Noble SM; Paige M
J Med Chem; 2019 Dec; 62(23):10605-10616. PubMed ID: 31751136
[TBL] [Abstract][Full Text] [Related]
20. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
